← Leaderboards
Erika E Ramsdale
University Of Rochester
$1,551,888
Attributed
$1,551,888
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $402.8K · FY2020–24$500K$375K$250K$125K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,551,888 · 2
By mechanism
K08$1,243,888 · 1
R03$308,000 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Rochester
Same institution · by research overlap
- Supriya G. Mohile$11,208,676
- Richard T Moxley$13,171,275
- Michael C Keefer$52,523,093
- Michelle C Janelsins$9,674,346
- Gloria S Pryhuber$27,133,178
Others in their field
Other Emerging Leaders on “Dose”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$124,321,134
- Beth Baseler · Leidos Biomedical Research, Inc.$52,807,683
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Paula Gonzalez-Maya · Fundacion Inciensa$37,578,679
- Xinhua Li · Nano Terra, Inc.$35,520,438
- Jeffrey Reich · Sparian Biosciences, Inc.$28,575,028
Research focus
DoseGeriatricsCommunity Clinical Oncology ProgramDevelopment PlansFallsFunctional StatusCluster Randomized TrialCohortClinical PharmacistsData ScienceElderlyEnrollmentAffectBenefits And RisksAdherenceClinicCancer TherapyAge RelatedCareer DevelopmentAgingAdverse OutcomeChemotherapyAreaHolly
Grant awards (7)
Decreasing Polypharmacy in Older Adults with Curable Cancers$248,780
K08 · FY2024 · CA · contact PI
Decreasing Polypharmacy in Older Adults with Curable Cancers$248,791
K08 · FY2023 · CA · contact PI
Decreasing Polypharmacy in Older Adults with Curable Cancers$248,780
K08 · FY2022 · CA · contact PI
Decreasing Polypharmacy in Older Adults with Curable Cancers$248,777
K08 · FY2021 · CA · contact PI
Polypharmacy, Potentially Inappropriate Medications, and Adverse Outcomes in Older Adults with Advanced Cancer Receiving Chemotherapy$154,000
R03 · FY2021 · AG · contact PI
Decreasing Polypharmacy in Older Adults with Curable Cancers$248,760
K08 · FY2020 · CA · contact PI
Polypharmacy, Potentially Inappropriate Medications, and Adverse Outcomes in Older Adults with Advanced Cancer Receiving Chemotherapy$154,000
R03 · FY2020 · AG · contact PI